Dr. Arun Manmadhan, MD

Dr. Manmadhan practices at Trustees of Columbia University in the City of New York in New York, New York.

Dr. Manmadhan's NPI, 1003262288, was assigned on May 6, 2016. Dr. Manmadhan graduated from New York University School of Medicine in 2016. Dr. Manmadhan holds New York license 292035.

Dr. Manmadhan's primary practice is Trustees of Columbia University in the City of New York, at 630 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 342-5155.

Dr. Manmadhan's primary practice is Trustees of Columbia University in the City of New York in New York, New York. Dr. Manmadhan is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Manmadhan to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Manmadhan practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Manmadhan's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Manmadhan is board certified in certification board of nuclear cardiology by the Alliance for Physician Certification & Advancement (APCA). Dmand AI has Dr. Manmadhan's licenses on file in 2 states: New York and New Jersey.

Dmand AI lists atrial fibrillation and flutter, cerebrovascular disease, chronic hypertension, coronary artery disease, heart blockage, heart failure, heart valve disorders and high cholesterol among the conditions Dr. Manmadhan treats.

CMS data shows 1,105 Medicare services from Dr. Manmadhan across 11 procedure codes in 2024, for 435 Medicare patients. Medicare paid $104,011 for them.

CMS counts 435 Medicare patients who saw Dr. Manmadhan in 2024. The largest group is 65 to 74, with 200 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.07, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Manmadhan's median patient age at 59, with 41% women.

In 2024, Dr. Manmadhan wrote 1,641 Medicare Part D claims for 272 patients. 80% of them were for generic drugs. CMS names the drug for 1,414 of them, across 23 drugs with 11 or more claims each, at $358,942 in total drug cost. In 2023, CMS named 944 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Manmadhan for performance year 2024, reported through an alternative payment model (APM). Dr. Manmadhan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Manmadhan as offering telehealth.

Dmand AI links 13 papers to Dr. Manmadhan, published from 2016 to 2021. 2021 was the busiest year, with 3. The most frequent topics are Anticoagulants, Atrial Fibrillation and COVID-19. Dr. Manmadhan's most frequent co-authors are Anthony Aizer, MD, Chirag Rashmi Barbhaiya, MD and Jeffrey Berger, MBA, MD.

CMS Open Payments shows 50 general payments to Dr. Manmadhan from 10 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 92% of the total. Amgen Inc. paid the most, $330.

Dmand AI lists 1 award for Dr. Manmadhan, most recently Chief Fellow in 2021.

Dr. Manmadhan graduated from New York University School of Medicine in 2016. Dr. Manmadhan is a member of ACC and AHA.

Dr. Manmadhan is in network with 15 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.